156 related articles for article (PubMed ID: 16286983)
1. Immunohistochemical localization of prostate-specific antigen in benign and malignant breast conditions.
Nariţa D; Raica M; Anghel A; Suciu C; Cîmpean A
Rom J Morphol Embryol; 2005; 46(1):41-5. PubMed ID: 16286983
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical detection of prostate specific antigen expression in human breast carcinoma cells.
Bodey B; Bodey B; Kaiser HE
Anticancer Res; 1997; 17(4A):2577-81. PubMed ID: 9252683
[TBL] [Abstract][Full Text] [Related]
3. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of prostate-specific antigen does not correlate to other prognostic factors in breast cancer.
Heyl W; Wolff JM; Biesterfeld S; Schröder W; Zitzelsberger D; Jakse G; Rath W
Anticancer Res; 1999; 19(4A):2563-5. PubMed ID: 10470195
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical detection of prostate specific antigen expression in human primary and metastatic melanomas.
Bodey B; Bodey B; Kaiser HE
Anticancer Res; 1997; 17(3C):2343-6. PubMed ID: 9216712
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen value as a marker in breast cancer.
Narita D; Cimpean AM; Anghel A; Raica M
Neoplasma; 2006; 53(2):161-7. PubMed ID: 16575473
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical detection of prostate-specific antigen (PSA) in skin adnexal and breast tissues and tumors.
Papotti M; Paties C; Peveri V; Moscuzza L; Bussolati G
Basic Appl Histochem; 1989; 33(1):25-9. PubMed ID: 2471501
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of transferrin in human breast cancer tissue.
Agarwal PK; Mehrotra A; Chandra T; Singh K
Indian J Pathol Microbiol; 2001 Apr; 44(2):107-11. PubMed ID: 11883122
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen in breast disease.
Poh BH; Jayaram G; Sthaneshwar P; Yip CH
Malays J Pathol; 2008 Jun; 30(1):43-51. PubMed ID: 19108411
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors.
Monne M; Croce CM; Yu H; Diamandis EP
Cancer Res; 1994 Dec; 54(24):6344-7. PubMed ID: 7527295
[TBL] [Abstract][Full Text] [Related]
11. Significance of micrometastases in pelvic lymph nodes detected by real-time reverse transcriptase polymerase chain reaction in patients with clinically localized prostate cancer undergoing radical prostatectomy after neoadjuvant hormonal therapy.
Miyake H; Kurahashi T; Hara I; Takenaka A; Fujisawa M
BJU Int; 2007 Feb; 99(2):315-20. PubMed ID: 17155986
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical labelling for prostate specific antigen in non-prostatic tissues.
Alanen KA; Kuopio T; Koskinen PJ; Nevalainen TJ
Pathol Res Pract; 1996 Mar; 192(3):233-7. PubMed ID: 8739470
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues.
Howarth DJ; Aronson IB; Diamandis EP
Br J Cancer; 1997; 75(11):1646-51. PubMed ID: 9184181
[TBL] [Abstract][Full Text] [Related]
14. [Determination of prostate-specific antigen (PSA) in cytosol of breast tumors and human endometrium--new diagnostic approaches].
Seliger E; Kaltwasser P; Röpke F
Zentralbl Gynakol; 1998; 120(4):172-5. PubMed ID: 9610520
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of prostate-specific antigen in female breast cancer.
Ilvan S; Celik V; Cetinaslan I; Calay Z; Ferahman M
J BUON; 2004; 9(2):183-6. PubMed ID: 17415812
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of prostate specific antigen (PSA) in benign and malignant tumors of the prostate.
Dema A; Tudose N
Rom J Morphol Embryol; 1998; 44(1-4):93-100. PubMed ID: 15678849
[TBL] [Abstract][Full Text] [Related]
17. Correlation of prostate specific antigen immunoactivity (IR-PSA) to other prognostic factors in female breast cancer.
Griniatsos J; Diamantis E; Gioti J; Karyda I; Vassilopoulos PP; Agnanti N
Anticancer Res; 1998; 18(1B):683-8. PubMed ID: 9584052
[TBL] [Abstract][Full Text] [Related]
18. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival.
Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G
Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536
[TBL] [Abstract][Full Text] [Related]
19. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.
Braun M; Flucke U; Debald M; Walgenbach-Bruenagel G; Walgenbach KJ; Höller T; Pölcher M; Wolfgarten M; Sauerwald A; Keyver-Paik M; Kühr M; Büttner R; Kuhn W
Breast Cancer Res Treat; 2008 Dec; 112(3):503-11. PubMed ID: 18165897
[TBL] [Abstract][Full Text] [Related]
20. Prostate specific antigen--new applications in breast and other cancers.
Diamandis EP
Anticancer Res; 1996; 16(6C):3983-4. PubMed ID: 9042323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]